#Long QT Syndrome Share
Explore tagged Tumblr posts
Text
Forecasting the Size of Long QT Syndrome Market
Market Overview –
The long QT syndrome market is anticipated to grow at a 5.2% CAGR from 2022 to 2030, or USD 3,933.02 million.
The Long QT Syndrome (LQTS) market encompasses medical interventions and devices designed to diagnose, treat, and manage this cardiac disorder characterized by abnormal heart rhythms. LQTS increases the risk of sudden cardiac arrest or arrhythmias, posing serious health threats. The market includes genetic testing, medications, implantable cardioverter-defibrillators (ICDs), and lifestyle modifications aimed at reducing the risk of life-threatening events.
The Long QT Syndrome market is characterized by advancements in understanding and managing this cardiac disorder. With a focus on long QT disorder, healthcare providers emphasize early diagnosis and personalized treatment approaches to mitigate the risk of life-threatening arrhythmias. As awareness grows, there's a rising demand for innovative therapies and genetic testing, driving market growth and research endeavors.
A key driver of the Long QT Syndrome market is the growing awareness of inherited cardiac disorders and advances in genetic testing technology. Early detection through genetic screening allows for timely interventions, such as medication adjustments or implantation of ICDs, to prevent cardiac events and improve patient outcomes.
Advancements in medical devices, such as miniaturized ICDs and wearable cardiac monitors, have revolutionized the management of Long QT Syndrome. These devices provide continuous monitoring and early detection of arrhythmias, offering peace of mind to patients and caregivers while improving overall safety.
The COVID-19 pandemic has impacted the Long QT Syndrome market, with disruptions in routine medical care, delayed diagnoses, and challenges in accessing specialized cardiac services. However, telemedicine and remote monitoring technologies have emerged as valuable tools in managing Long QT Syndrome, enabling patients to receive timely care and support from healthcare providers.
Segmentation –
The global long QT syndrome market is segmented on the basis of type, diagnosis, treatment, and end users. On the basis of the type, the market is segmented into long QT syndrome type 1, long QT syndrome type 2, long QT syndrome type 3, and others.  On the basis of the diagnosis, the market is categorized into tests, electrocardiogram (ECG), genetic testing, and others.
On the basis of the treatment, the market is segmented into medication, surgical procedures, and others.  On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic labs, research organizations, and others.
Regional Analysis –
Regional analysis of the Long QT Syndrome (LQTS) market reveals variations in diagnosis rates, treatment options, and healthcare infrastructure across different regions. In developed regions like North America and Europe, where there is greater awareness of genetic disorders and access to specialized cardiac care, the market for LQTS diagnostics and management is well-established, with genetic testing, beta-blockers, and implantable cardioverter-defibrillators (ICDs) being standard of care.
Conversely, in developing regions with limited access to advanced cardiac diagnostics and therapies, such as parts of Africa and Asia-Pacific, the market for LQTS is still emerging, with challenges related to underdiagnosis and limited treatment options. Moreover, cultural attitudes towards genetic testing and preventive healthcare influence patient behaviors and healthcare-seeking patterns across different regions. As awareness of LQTS and its genetic basis increases globally, there is a growing opportunity for market expansion through education, advocacy, and investment in cardiac care infrastructure to improve outcomes for LQTS patients worldwide.
Key Players –
Long QT syndrome key players include Invitae Corporation (U.S.), GeneDx (U.S.), Asper Biogene (Estonia), Boston Scientific Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), Pfizer Inc. (U.S.), Zydus Pharmaceuticals, Inc. (U.S.), Aralez Pharmaceuticals Inc. (Canada), AstraZeneca (U.K.), Torrent Pharmaceuticals Limited (India), Lupin Pharmaceuticals, Inc. (U.S.), Cipla Inc. (India), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), and others.
Related Reports –
Pain Patch
Electronic Trial Master File Systems
Neurology Devices
Medical Payment Fraud Detection
For more information visit at MarketResearchFuture
0 notes
yet-another-heathen · 6 months ago
Note
4. Is there a kind of whump you wish you could write better?
12. What is one of the strangest things you have had to research for your whumpy writing?
25. What advice or wisdom would you like to share with other whump writers?
4. Is there a kind of whump you wish you could write better?
As I recently discovered with @redwingedwhump, the hardest thing for me to write is actually recovery arcs. Stories that have slow, emotional pacing and tend to be more driven by internal conflict than by external forces. I'm thinking specifically recoveries where the character(s) are already somewhere stable and safe, and are having to come to terms with things that already happened to them (instead of facing ongoing re-traumatization at the hands of the Plot).
And don't get me wrong, I still do enjoy writing slow, heavy scenes where not much physically happens! They're just as important to the story as a whole, and they can be a LOT of fun to read. But I can only write them in the context of shorter scenes within a larger story, where the emotions serve as a pause from the forward momentum of the plot. When those emotions are meant to provide the momentum on their own...that's when my skill set tends to feel stretched. (For the time being!)
12. What is one of the strangest things you have had to research for your whumpy writing?
Oh man... that's a hard one, because I don't really consider any of it strange. Niche, yes. Unusual, perhaps. But my deepest research dives have been into what it's like to live as an upper-limb amputee. Or into what medications are most useful for treating Long QT Syndrome, or what having an ICD go off feels like. Or alternatively, about foods and wildlife found in and around the ancient Syrian desert. Or about laqabs (that one was fun). None of it is actually strange, it's just about understanding the experiences of people whose stories we don't get to find unless we go digging.
25. What advice or wisdom would you like to share with other whump writers?
Take advantage of occasional unsanitary descriptions! Don't be afraid to make the things that happen to your characters be embarrassing and gross! I know we all love the pretty kinds of pain, but I feel like we shoot ourselves in the foot by leaving out the stuff that's gross or humiliating. If your whumpee is crying themselves sick, let them get snot on their face! If they just had a near-death experience, let them realize that they lost control of their bladder! If they're being kept like an animal in a cage, let them face ALL the consequences of ending up without a bathroom!
Those descriptions can each be incredibly brief, but just acknowledging that they're happening at all brings the whole story back to reality. If you go too long without them, your suspension of disbelief starts working against you. The whump your character is going through starts to seem oddly natural. Until suddenly there's something there that gives you just that tiiiiny jolt of "....oh. Oh god. It really is that bad, isn't it?" that truly renews the horror of what you're reading. There aren't many things that can have such a big impact on the overall reading experience of your story in so few words.
And besides, when you find various ways to take away the dignity of your characters (and I mean ALL of your characters, not just your whumpees), it's SO FREEING. You learn that you don't need your Aloof Dignified character to be aloof and dignified 100% of the time. And that in fact, when you find ways to take that defining trait away from them and they still come back to it after, that makes the character trait ten times stronger than it was before. Perfection kills personality. Humiliate everybody, and you'll see what they're actually made of.
5 notes · View notes
kbc-78 · 3 months ago
Text
The Role of Genetics in Heart Disease
Heart disease is a leading cause of morbidity and mortality worldwide. While lifestyle factors such as diet, exercise, and smoking play significant roles in its development, genetics also has a crucial influence. Understanding the genetic components of heart disease can help in identifying individuals at risk and developing personalized prevention and treatment strategies. Dr. Kartik Bhosale emphasizes the importance of genetic screening and tailored medical care to effectively manage and prevent heart disease. The Best Cardiologist in Pune can offer the expertise and guidance necessary for optimal heart health management.
How Genetics Influence Heart Disease?
Inherited Genetic Mutations:
Description: Certain genetic mutations can be passed down from parents to offspring, increasing the risk of developing heart disease.
Examples: Mutations in genes like LDLR (low-density lipoprotein receptor) can lead to familial hypercholesterolemia, a condition characterized by high cholesterol levels and an increased risk of coronary artery disease.
Family History:
Description: A family history of heart disease significantly raises an individual’s risk of developing similar conditions.
Explanation: If close relatives have heart disease, it indicates a potential genetic predisposition, possibly combined with shared lifestyle factors.
Polygenic Risk:
Description: Heart disease often results from the combined effect of multiple genes, each contributing a small amount to the overall risk.
Examples: Polygenic risk scores, which aggregate the effects of many genetic variants, can predict an individual’s likelihood of developing heart disease.
Specific Genetic Conditions Related to Heart Disease:
Familial Hypercholesterolemia:
Cause: Mutations in the LDLR, APOB, or PCSK9 genes.
Effect: Elevated LDL cholesterol levels, leading to an increased risk of coronary artery disease.
Hypertrophic Cardiomyopathy:
Cause: Mutations in genes like MYH7, MYBPC3.
Effect: Thickening of the heart muscle, which can cause arrhythmias and heart failure.
Dilated Cardiomyopathy:
Cause: Mutations in genes such as TTN, LMNA.
Effect: Enlargement and weakening of the heart chambers, leading to heart failure and arrhythmias.
Long QT Syndrome:
Cause: Mutations in genes like KCNQ1, KCNH2.
Effect: Prolonged QT interval on the ECG, leading to an increased risk of sudden cardiac death.
Genetic Testing and Counseling:
Predictive Genetic Testing:
Purpose: Identifies individuals at high risk for specific genetic heart conditions.
Benefit: Allows for early intervention and personalized management strategies to reduce the risk of heart disease.
Carrier Testing:
Purpose: Determines if an individual carries a gene mutation that could be passed to their offspring.
Benefit: Helps in family planning and understanding the risk of hereditary heart conditions.
Genetic Counseling:
Purpose: Provides information and support to individuals and families with a history of genetic heart conditions.
Benefit: Helps in making informed decisions about testing, treatment, and lifestyle changes.
The Interaction Between Genetics and Lifestyle:
While genetics play a significant role in heart disease, lifestyle factors can either exacerbate or mitigate genetic risks. To address both genetic and lifestyle aspects of heart health, consider consulting Dr. Kartik Bhosale for expert guidance and personalized care.
For example:
Diet: A healthy diet can help manage cholesterol levels, even in individuals with genetic predispositions.
Exercise: Regular physical activity can improve heart health and counteract genetic risks.
Smoking: Avoiding smoking can significantly reduce the risk of heart disease, particularly in those with genetic susceptibility.
Future Directions in Genetic Research:
Personalized Medicine:
Description: Tailoring prevention and treatment strategies based on an individual’s genetic profile.
Potential: Improves the efficacy and reduces side effects of treatments for heart disease.
Gene Therapy:
Description: Techniques aimed at correcting or compensating for defective genes responsible for heart disease.
Potential: Offers hope for curing or significantly altering the course of genetic heart conditions.
CRISPR and Genetic Editing:
Description: Advanced technologies like CRISPR allow for precise editing of genetic material.
Potential: Could be used to correct genetic mutations associated with heart disease in the future.
Conclusion:
Genetics plays a pivotal role in the development and progression of heart disease. By understanding the genetic factors involved, we can better identify individuals at risk and develop targeted prevention and treatment strategies. As research advances, the integration of genetic information into clinical practice holds promise for improving outcomes and reducing the burden of heart disease. If you have a family history of heart disease or are concerned about your genetic risk, consider consulting Dr. Kartik Bhosale, a Heart Specialist in Pune, to explore your options.
0 notes
hellocitalopramdiaries · 5 years ago
Text
Citalopram Generic Name: citalopram (si TAL o pram) Brand Names: CeleXA
Medically reviewed by Sanjai Sinha, MD Last updated on Dec 19, 2018.
What is citalopram?
Citalopram is an antidepressant belonging to a group of drugs called selective serotonin reuptake inhibitors (SSRIs).
Citalopram is used to treat depression.
Citalopram may also be used for purposes not listed in this medication guide.
Important information You should not use citalopram if you also take pimozide, or if you are being treated with methylene blue injection.
Do not use citalopram if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.
Some young people have thoughts about suicide when first taking an antidepressant. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.
Report any new or worsening symptoms to your doctor, such as: mood or behaviour changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Do not give citalopram to anyone younger than 18 years old without the advice of a doctor. This medicine is not approved for use in children.
Before taking this medicine You should not use this medicine if you are allergic to citalopram or escitalopram (Lexapro), or if you also take pimozide.
Do not use citalopram if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
To make sure citalopram is safe for you, tell your doctor if you have:
a bleeding or blood clotting disorder;
liver or kidney disease;
narrow-angle glaucoma;
seizures or epilepsy;
heart disease, heart failure, a heart rhythm disorder, slow heartbeats, or recent history of heart attack;
personal or family history of Long QT syndrome;
an electrolyte imbalance (such as low levels of potassium or magnesium in your blood);
bipolar disorder (manic depression); or
a history of drug abuse or suicidal thoughts.
Some young people have thoughts about suicide when first taking an antidepressant. Your doctor should check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.
Taking an SSRI antidepressant during pregnancy may cause serious lung problems or other complications in the baby. However, you may have a relapse of depression if you stop taking your antidepressant. Tell your doctor right away if you become pregnant. Do not start or stop taking this medicine during pregnancy without your doctor's advice.
Citalopram can pass into breast milk and may harm a nursing baby. You should discuss the risks and benefits of using citalopram if you are breast-feeding.
Do not give this medicine to anyone under 18 years old without medical advice. Citalopram is not approved for use in children.
How should I take citalopram? Take citalopram exactly as prescribed by your doctor. Follow all directions on your prescription label. Your doctor may occasionally change your dose. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Measure liquid medicine with the dosing syringe provided, or with a special dose-measuring spoon or medicine cup. If you do not have a dose-measuring device, ask your pharmacist for one.
It may take up to 4 weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.
Do not stop using citalopram suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using this medicine.
Store at room temperature away from moisture and heat.
See also: Citalopram dosage information (in more detail)
What happens if I miss a dose? Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
What happens if I overdose? Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking citalopram? Ask your doctor before taking a nonsteroidal anti-inflammatory drug (NSAID) for pain, arthritis, fever, or swelling. This includes aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib (Celebrex), diclofenac, indomethacin, meloxicam, and others. Using an NSAID with citalopram may cause you to bruise or bleed easily.
Drinking alcohol can increase certain side effects of citalopram.
Citalopram may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.
Citalopram side effects Get emergency medical help if you have signs of an allergic reaction to citalopram: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if you have:
a light-headed feeling, like you might pass out;
blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
severe nervous system reaction--very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out;
high levels of serotonin in the body--agitation, hallucinations, fever, fast heart rate, overactive reflexes, nausea, vomiting, diarrhea, loss of coordination, fainting; or
low levels of sodium in the body--headache, confusion, slurred speech, severe weakness, vomiting, feeling unsteady.
Common citalopram side effects may include:
problems with memory or concentration;
headache, drowsiness;
dry mouth, increased sweating;
numbness or tingling;
increased appetite, nausea, diarrhea, gas;
fast heartbeats, feeling shaky;
sleep problems (insomnia), feeling tired;
cold symptoms such as stuffy nose, sneezing, sore throat;
changes in weight; or
difficulty having an orgasm.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Citalopram side effects (in more detail)
What other drugs will affect citalopram? Taking citalopram with other drugs that make you sleepy or slow your breathing can cause dangerous side effects or death. Ask your doctor before taking a sleeping pill, narcotic pain medicine, prescription cough medicine, a muscle relaxer, or medicine for anxiety, depression, or seizures.
Many drugs can interact with citalopram. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any you start or stop using, especially:
cimetidine;
lithium;
St. John's wort;
tryptophan (sometimes called L-tryptophan);
a blood thinner (warfarin, Coumadin, Jantoven);
any other antidepressant;
heart medication;
medicine to treat a psychiatric disorder; or
"triptan" migraine headache medicine.
This list is not complete and many other drugs can interact with citalopram. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.
See also: Citalopram drug interactions (in more detail)
Further information Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use citalopram only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2020 Cerner Multum, Inc. Version: 20.01.
Related questions What are some common side effects of antidepressants? SSRI’s vs SNRI’s - What's the difference between them? What is the difference between Celexa and Lexapro?
Medical Disclaimer
1 note · View note
dawson64willumsen-blog · 6 years ago
Text
9 Ideal Drugstore Acne Products For 2016.
Scientists have actually noted there are associations between self-reported sleep duration as well as drinking of sugar-sweetened beverages. Dr Doug Brown, of the Alzheimer's Society, stated: 'Evaluating drugs already in operation for other problems is a priority for Alzheimer's Society - it can allow us to route the 15 years or two had to develop a new dementia medicine from scratch. If a job requires your complete focus, then arrange it for a while of day when you have the power should focus.. With some drugs, reduced degrees of abnormal liver enzymes prevail as well as don't appear to be connected with essential (serious or modern) liver disease, as well as the individual may proceed taking the medication. It has actually been utilized for a long period of time in traditional medication as an antispasmodic and anticonvulsant.
In the most recent noise Seale sourced his medications from 2 calls he fulfilled in Amsterdam and had them packed right into boxes which declared to be various type of tinned vegetables and fruit. Ask your doctor before taking a sleeping pill, narcotic pain medicine, prescription cough medication, a muscle relaxer, or medication for anxiety, anxiety, or seizures. Like other big companies before it, consisting of Walmart and also Google, Apple just recently got a federal designation for its energy subsidiary that enables it to come to be a wholesale vendor of electrical power from coast to coastline. Glucose is the key fuel made use of by a lot of cells in the body to create the power that is should carry out mobile features. Fatalities by overdose have relocated lock action with the rising availability of the drug: From late 2013 to late 2014, the most current years available, greater than 700 Americans died from fentanyl-related overdoses. You should not take any tablets consisting of fenfluramine, sibutramine, ephedra, ephedrine, ma huang, country mallow and also heartleaf. After graduating from St. http://caleaspresanatate.info of Medicine, he finished his Inner Medication residency and also Rheumatology fellowship at the College of California, Irvine. More about the author take multivitamins, probiotics, and also vitamin D. I likewise acquired a Huge Wheel tricycle for Egypt and also spent for his college applications. Since that time, there has been a surge of interest in the United States and Europe in the application of the strategy of acupuncture to Western medicine. This guide to getting therapy for a medication problem will steer you through the choices, so you can discover aid that benefits you. Much like with sex education and learning, we understand that abstinence-only medication education and learning programs do not work. Some medicines can interact with methadone as well as cause a significant condition called serotonin syndrome Be sure your doctor understands if you also take medicine for depression, mental illness, Parkinson's disease, migraine headaches, severe infections, or avoidance of queasiness as well as throwing up. Mr Dennis, who is to release a major research study of substance abuse later this year, included: 'This degree of substance abuse is welcoming catastrophe for children. I'm fascinated by the neuro-protective research by Raphael Meschoulam in Israel, and also research in Israel and the United States on whether the medication may help alleviate signs and symptoms of PTSD I assure to do my part to assist, truly as well as honestly, fill up the remaining gap in our expertise. Consider this checklist of the 26 finest drugstore appeal item acquires as your means to financial and aesthetic happiness. In the very first part of the pooled analysis, the scientists checked out the QT interval - a segment of the heart's rhythm - of 93 individuals who had simply eaten one to three cans of energy drinks. As a result, cells need to regularly expend power originated from the environment. Fifty percent of the examination houses likewise have power storage systems with LG batteries and also Eguana inverters, which assist handle the flow of electrical energy in between the solar installment, house and grid, to permit researchers to examine and also contrast what does it cost? worth they include. These 2 strategies produce 2 types of chemical bonds between atoms: an ionic bond is formed when electrons are donated by one atom to one more, whereas a covalent bond is created when 2 atoms share a set of electrons (Figure 2-5 ). Often, both of electrons is shared unequally, with a partial transfer between the atoms; this intermediate method leads to a polar covalent bond, as we will talk about later. Frequency researches of substance use and also abuse in lesbian, gay, as well as bisexual populations seldom have consisted of adequate varieties of racial as well as ethnic minority persons to allow separate evaluations. Meticulously follow the application instructions offered with your kid's medicine for the age as well as weight of your child. Analysis of NHS medication costs shows a number of other huge price boosts entailing various other generic makers. As Shelby looks to medications to numb her discomfort, she forms an unlikely friendship with her dope dealer, Ben, a previous senior high school classmate, and the pair makes a decision to go to New York City to live. The reasons for the European offshore wind energy boom are manifold: For one, European governments as well as the EU all at once have actually sustained wind jobs with favorable incentives as part of their CARBON DIOXIDE decrease objectives. A drug offense will likewise get you and also your whole family tossed out of public real estate. I really despise those tablets they drop my blood glucose to reduced and also I pass out in the street. But because the cost is covered right into the home loan, and paid over a prolonged amount of time, it is more easily economical, as well as the bigger settlements are typically balanced out by the cost savings on power bills. Keep in mind: Very little therapy research is offered pertaining to substance abuse therapy among Eastern- and Pacific-American females. Alcohol could engage with several courses of medication to produce major CNS depression. The examination procedure is fairly easy and provides results in 3 to eight mins, making it an useful device for work-related medicine centers as well as law enforcement authorities. Ebico, which works in collaboration with SSE, is the UK's only not-for-profit power firm as well as materials more than 60,000 customers. The research study found that fewer than half the youngsters who confessed using drugs were considered having 'high self-confidence' against more than three- quarters of non-drug customers. Coming quickly (read: in March 2015) to a shop near you: These glosses (shown below in Grasping at Strawberries as well as She Sells) are as shiny as the coating on a brand-new sports car, and they make lips look plump. Aslan reportedly tested the medicine in a large double-blind, placebo-controlled research study that included 15,000 employees throughout Romania. Instead, on days when the wind is variable, it takes in added energy when a gust comes with, and presses the power back right into the grid when the wind makers are all of a sudden calmed, to smooth out the variation in the ranch's output. Existing tests of the medicines on clients with leukaemia suggest they are well-tolerated, offering premises for optimism, she claimed.
1 note · View note
marketreports-world · 3 years ago
Link
0 notes
techscimarketresearch · 3 years ago
Text
United States Pacemaker Market to Register Healthy Growth through 2025 | TechSci Research
Increasing cases of cardiovascular diseases and technological advancements in healthcare to drive United States pacemaker market.
Tumblr media
According to TechSci Research report, “United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025”, the market is anticipated to grow at a significant CAGR during the forecast period. Key factors propelling the growth of United States pacemaker market include increasing prevalence of cardiovascular diseases and the spread of COVID-19, which has led to high spread of CVDs among patients suffering from coronavirus. The increasing demand for minimally invasive procedures is also creating high demand for pacemakers in United States market. Furthermore, technological advancements and launch of new products such as leadless pacemakers and MRI safe pacemakers are expected to propel the market growth in coming years. Also, favorable government policies and increasing expenditure on healthcare sector are supporting the growth of United States pacemaker market.
Additionally, favorable reimbursement procedures such as Medicare system coupled with rise in manufacturing high-end pacemakers, which caters to customized care are fueling the growth of United States pacemaker market. Along with this, growing geriatric population who are more vulnerable to cardiovascular diseases is also acting as a major growth driver for this market. The advent of battery free pacemakers has brough revolutionary change in the market and is augmenting the market growth. With increasing FDA approval for novel pacemakers, the market is expected to witness substantial growth through 2025. However, pacemaker devices cost two to six times more in the United States than in European countries such as Germany. This might hinder the United States pacemaker market growth.
Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on "United States Pacemaker Market"
https://www.techsciresearch.com/report/united-states-pacemaker-market/5173.html
The United States pacemaker market is segmented based on type, product type, application, technology, end user and region. Based on application, the market can be segmented into heart block, arrhythmia, atrial fibrillation, bradycardia, tachycardia, and long QT syndrome. Among them, atrial fibrillation is expected to hold a significant share in United States pacemaker market during the forecast period. According to CDC, around 2.7–6.1 million people in the United States have atrial fibrillation, which is the most common type of heart arrhythmia. The number is expected to increase over the coming years.
Based on technology, United States pacemaker market can be segmented into single chamber, dual chamber, and CRT-P/biventricular pacemakers. Among them, dual-chamber pacemakers held significant share in United States market in 2019, owing to reduced post-surgical complications and presence of two leads which assure normal physiology of the heart. However, CRT-P, also known as biventricular pacemakers, are expected to register fastest growth in United States pacemaker market during the forecast period as they are increasingly being used to treat people with arrhythmias caused by advanced heart failure. These pacemakers contain three leads which are connected to the right atrium and both ventricles.
Major players operating in the United States pacemaker market include Biotronik, Inc., Boston Scientific Corporation, Abbot Inc., Zoll Medical Corporation, Oscor Inc., Medtronic, Inc., Cordis, Inc., Livanova PLC, Medico Inc., Oscor Inc. and Osypka Medical Inc. Leading companies are undertaking growth strategies such as new product launches, mergers & acquisitions, and partnerships.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5173
Customers can also request for 10% free customization on this report.
“The introduction of U.S. Food and Drug Administration (FDA)-cleared MRI-conditional pacemaker models are a growing trend in United States. Around 20% of pacemaker patients need an MRI within the first two years of implant. Pacemakers which do not have MRI-conditional use technology, generally prevent patients from being able to get an MRI. With increasing cases of cardiovascular diseases in the country, more manufacturers are coming up with advanced products and are using MRI-conditional use technology,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of United States pacemaker market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States pacemaker market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
0 notes
techsciresearch · 3 years ago
Text
United States Pacemaker Market to Register Healthy Growth through 2025 | TechSci Research
Increasing cases of cardiovascular diseases and technological advancements in healthcare to drive United States pacemaker market.
Tumblr media
According to TechSci Research report, “United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025”, the market is anticipated to grow at a significant CAGR during the forecast period. Key factors propelling the growth of United States pacemaker market include increasing prevalence of cardiovascular diseases and the spread of COVID-19, which has led to high spread of CVDs among patients suffering from coronavirus. The increasing demand for minimally invasive procedures is also creating high demand for pacemakers in United States market. Furthermore, technological advancements and launch of new products such as leadless pacemakers and MRI safe pacemakers are expected to propel the market growth in coming years. Also, favorable government policies and increasing expenditure on healthcare sector are supporting the growth of United States pacemaker market.
Additionally, favorable reimbursement procedures such as Medicare system coupled with rise in manufacturing high-end pacemakers, which caters to customized care are fueling the growth of United States pacemaker market. Along with this, growing geriatric population who are more vulnerable to cardiovascular diseases is also acting as a major growth driver for this market. The advent of battery free pacemakers has brough revolutionary change in the market and is augmenting the market growth. With increasing FDA approval for novel pacemakers, the market is expected to witness substantial growth through 2025. However, pacemaker devices cost two to six times more in the United States than in European countries such as Germany. This might hinder the United States pacemaker market growth.
Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on "United States Pacemaker Market"
https://www.techsciresearch.com/report/united-states-pacemaker-market/5173.html
The United States pacemaker market is segmented based on type, product type, application, technology, end user and region. Based on application, the market can be segmented into heart block, arrhythmia, atrial fibrillation, bradycardia, tachycardia, and long QT syndrome. Among them, atrial fibrillation is expected to hold a significant share in United States pacemaker market during the forecast period. According to CDC, around 2.7–6.1 million people in the United States have atrial fibrillation, which is the most common type of heart arrhythmia. The number is expected to increase over the coming years.
Based on technology, United States pacemaker market can be segmented into single chamber, dual chamber, and CRT-P/biventricular pacemakers. Among them, dual-chamber pacemakers held significant share in United States market in 2019, owing to reduced post-surgical complications and presence of two leads which assure normal physiology of the heart. However, CRT-P, also known as biventricular pacemakers, are expected to register fastest growth in United States pacemaker market during the forecast period as they are increasingly being used to treat people with arrhythmias caused by advanced heart failure. These pacemakers contain three leads which are connected to the right atrium and both ventricles.
Major players operating in the United States pacemaker market include Biotronik, Inc., Boston Scientific Corporation, Abbot Inc., Zoll Medical Corporation, Oscor Inc., Medtronic, Inc., Cordis, Inc., Livanova PLC, Medico Inc., Oscor Inc. and Osypka Medical Inc. Leading companies are undertaking growth strategies such as new product launches, mergers & acquisitions, and partnerships.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5173
Customers can also request for 10% free customization on this report.
“The introduction of U.S. Food and Drug Administration (FDA)-cleared MRI-conditional pacemaker models are a growing trend in United States. Around 20% of pacemaker patients need an MRI within the first two years of implant. Pacemakers which do not have MRI-conditional use technology, generally prevent patients from being able to get an MRI. With increasing cases of cardiovascular diseases in the country, more manufacturers are coming up with advanced products and are using MRI-conditional use technology,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of United States pacemaker market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States pacemaker market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
0 notes
market-research-future · 3 years ago
Text
Long QT Syndrome Market Overview, Economic Impact, Dynamics and SWOT Analysis To 2027
Market Highlights
The market of Long QT syndrome (LQTS) is driven by factors like the prevalence of cardiovascular diseases & diabetes, and growing geriatric population. Moreover, rising per capita healthcare expenditure and increasing R&D expenses by the key players is fuelling the market growth over the forecast period. However, lack of awareness and stringent FDA approvals followed by the high cost of the surgical therapeutics pertaining to this disorder are restraining the market growth.
The global long QT syndrome market is expected to grow at a CAGR of 8.50% during the forecast period.
Segmentation
The global long QT syndrome market is segmented on the basis of type, diagnosis, treatment, and end users. On the basis of the type, the market is segmented into long QT syndrome type 1, long QT syndrome type 2, long QT syndrome type 3, and others.  On the basis of the diagnosis, the market is categorized into tests, electrocardiogram (ECG), genetic testing, and others.
On the basis of the treatment, the market is segmented into medication, surgical procedures, and others.  On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic labs, research organizations, and others.
Regional Analysis
The Americas dominate the global long QT syndrome market. A well-developed healthcare sector, high per capita healthcare expenditures, increasing number of patients suffering from cardiovascular diseases and diabetes are the major drivers for long QT syndrome market in the Americas. Moreover, the presence of developed economies like the U.S. and Canada boosts the market growth within this region.
Europe holds the second largest market share. Availability of funds for research, huge patient population, and government support for research & development will drive the market. Regionally, Europe is divided into Western Europe and Eastern Europe. The Western Europe leads the market within the Europe. However, Eastern Europe is estimated to be the fastest growing region.
Browse Full Report @ https://www.marketresearchfuture.com/reports/long-qt-syndrome-market-5303 .
Asia Pacific is the fastest growing market. Increasing prevalence of diabetes and growing geriatric population are the major driving factors for the market growth within the region. Moreover, the presence of developing healthcare sector and developing economies within the region are boosting the market growth.
The Middle East & Africa holds the least share of the market. Presence of poor economies and stringent government policies especially in the Africa region are the restraining factors for market growth within the region. The Middle East holds a major share of the market within the region. This can be attributed due to huge healthcare expenditures by the developed economies of the region.
Key Players
The key players for the global long QT syndrome market are Invitae Corporation (U.S.), GeneDx. (U.S.), Asper Biogene (Estonia), Boston Scientific Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), Pfizer Inc. (U.S.), Zydus Pharmaceuticals, Inc. (U.S.), Aralez Pharmaceuticals Inc. (Canada), AstraZeneca (U.K), Torrent Pharmaceuticals Limited (India), Lupin Pharmaceuticals, Inc. (U.S.), Cipla Inc. (India), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), and others.
Browse Related Reports at:
Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR
Migraine Drugs Market by Type, Drug Class, Growth Analysis Till 2027 | MRFR
Patient Registry Software Market Size, Share, Type, Global Analysis, 2027 | MRFR
0 notes
businesspr · 4 years ago
Text
Long QT Syndrome Treatment Market Report With Top Countries data, Trend, CAGR Status, shares, opportunities and growth forecast to 2026
Long QT Syndrome Treatment Market Report With Top Countries data, Trend, CAGR Status, shares, opportunities and growth forecast to 2026
The Global Long QT Syndrome Treatment Market report provides information by Top Players, Geography, End users, Applications, Competitor analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends, and Forecast. The latest research study titled Global  Long QT Syndrome TreatmentMarket Research Report 2021 by Market.biz contains all analytical and statistical brief summary…
View On WordPress
0 notes
kunalcmi · 4 years ago
Text
ECG MONITORING SYSTEMS MARKET ANALYSIS(2020-2027)
An electrocardiogram (ECG or EKG) records the electrical signal from the heart to check for different heart conditions. It is the most important test for interpretation of the cardiac rhythm, detection of myocardial ischemia and infarction, conduction system abnormalities, preexcitation, long QT syndromes, atrial abnormalities, ventricular hypertrophy, pericarditis, and other conditions.
The global ECG monitoring systems market is estimated to account for US$ 1,102.5 Mn in terms of value in 2020 and is expected to reach US$ 1,847.2 Mn by the end of 2027.
 Global ECG Monitoring Systems Market: Drivers
Increasing prevalence of cardiovascular diseases is expected to propel growth of the global cardiovascular monitoring and diagnostic devices market over the forecast period. For instance, according to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.   
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     
ECG Monitoring Equipment held dominant position in the global ECG monitoring systems market in 2019, accounting for 56.5% share in terms of value, followed by Holter Monitoring Systems and ECG Stress Testing Systems, respectively.
 Figure 1. Global ECG Monitoring Systems Market Share (%), by Value, by Equipment Type, 2019
Tumblr media
Global ECG Monitoring Systems Market: Restraints
Inaccuracy of wearable ECG devices is expected to hinder growth of the market. For instance, according to a research published in April 2019 by the Harvard Medical School, 30% of wearable devices yield inaccurate results.
Moreover, handheld ECG devices offer limited information compared to conventional lead ECGs, which is also expected to limit growth of the market.
Tumblr media
Global ECG Monitoring Systems Market: Opportunities 
R&D in ambulatory ECGs is expected to offer lucrative growth opportunities for players in the global ECG monitoring systems market. For instance, in February 2020, researchers at University of Electronic Science and Technology of China developed an adaptive cancellation algorithm based on multi-inertial sensors to suppress motion artifacts in ambulatory ECGs.
Moreover, increasing investment in development of new devices is also expected to aid in growth of the market. For instance, in December 2019, Biotricity Inc., a medical diagnostic and consumer healthcare technology company, raised US$ 6 million for FDA Filing for its patch solution within the first 6 months of 2020, which will be a novel product in the field of Holter monitoring.
Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/4027
Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/4027
The global ECG monitoring systems market was valued at US$ 1,024.4 Mn in 2019 and is forecast to reach a value of US$ 1,847.2 Mn by 2027 at a CAGR of 7.7% between 2020 and 2027.
Figure 2. Global ECG Monitoring Systems Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027
Tumblr media
Market Trends/Key Takeaways
The market is witnessing development of web-based remote cardiac monitoring solutions. For instance, in November 2019, Bittium Corporation, a Finland-based cardiology and neurology device company, presented Bittium HolterPlus, a web-based remote cardiac monitoring solution, consisting of a Bittium Faros ECG device and Bittium HolterPlus mobile application, at Medica 2019, a leading international trade fair for the medical sector that was held in Germany.
R&D in ECG-enabled smartwatch is aiding in growth of the market. For instance, in February 2020, Johnson & Johnson launched a new, virtual clinical study to determine the efficacy of Apple’s iPhone and ECG-enabled smartwatch in reducing the risk of stroke and detecting cases of atrial fibrillation.
Global ECG Monitoring Systems Market: Competitive Landscape
Major players operating in the global ECG monitoring systems market include, GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd., OSI Systems, Lidco Group plc, Biotricity Inc., Bittium Corporation, St. Jude Medical Inc., VivaQuant, and Johnson & Johnson.
Global ECG Monitoring Systems Market: Key Developments
Major players in the market are focused on approval and launch of new devices to expand their product portfolio. For instance, in July 2020, AliveCor released KardiaCare, a digital subscription service that offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes.
Similarly, in January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient monitoring, received the U.S. FDA clearance for its Continuous ECG platform comprising of reusable wearable ECG sensors and associated software development kit
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
 What we provide:
Customized Market Research Services
Industry Analysis Services
Business Consulting Services
Market Intelligence Services
Long term Engagement Model
Country Specific Analysis
Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Source: https://www.coherentmarketinsights.com/market-insight/ecg-monitoring-systems-market-4027
0 notes
drferox · 8 years ago
Text
20 Questions with Dr Ferox #8
My gosh, there’s just so much stuff you vetlings want to know, isn’t there? Well, knowledge is good, so here we go with yet another info dump as I try to answer a big slew of your questions in one hit.
Anonymous said: I sometimes get your patreon emails or an update on your blog while I'm studying/struggling in the wee-hours of the morning (vetmed). I'm in WA, so where-ever you are it's also late/early. What are you doing up in the witching hours?
First of all, I am an AdultTM and as such I am permitted to set by own Bed Time. There are many reasons why you might receive notifications from me so ‘early’.
I have a blog post on queue every morning between 5am and 6am my time (so probably 3am and 4am your time). It goes up automatically, so I can see initial responses before I go to work.
I think Patreon sends its emails at the same time each day, regardless of when I post. I certainly don’t type there early in the morning.
Sometimes I’m on nightshift and can get kinda bored at 3am sometimes.
Sometimes I just can’t sleep, especially with the changing day/night cycles.
Most of the blog runs on queue, honestly. At least three posts a day do.
@banesidhe said: Just happened to discover your blog. Thank you so much for posting like you do (even the snark. I'm a 911 dispatcher, I appreciate the snark ;) ), and sharing your experiences. No vet question, but if you could only ever re/read five books for the rest of your life, which five titles would make your cut?
Ah, I have found many similar people to myself among emergency personnel. There’s a particular combination of gallows humor and wishing people would get to the point that unites us.
For fiction books:
Feral, Kerry Greenwood
The Shepherd’s Crown, Terry Pratchett
Monstrous Regiment, Terry Pratchett
Watership Down, Richard Adam
Good Omens, Terry Pratchett & Neil Gaiman
Hmm, bit of a trend there.
But the work books I couldn’t live without are:
Plumb’s Veterinary Drug Handbook
The 5 minute veterinary consult, Dog and Cat Edition
Ettinger’s Textbook of Internal Medicine, Expert Consult
BSAVA Rabbit Medicine & Surgery Handbook
Small Animal Surgery, Fossum.
Anonymous asked: what was the most exotic/rare patient youve ever had?
This fat meerkat.
Anonymous said: My dog is a shelter dog and we suspect she was abused before we got her (afraid of E V E R Y T H I N G) and weve been slowly working on getting her to at least ignore people we walk past or that enter the house and thats been making progress. But she hates the vet. Hates it. Gets in my lap and refuses to leave. New dogs people and smells. So her normal vet takes the approach of having one of us hold/console her while they do all the poking and listening and whatnot and muzzling her if they need to and just getting it done as quickly as possible. But this last time she saw a new vet and this vet took the approach of hand-feeding her almost an entire bag of treats and called it "stress-eating" and tbh you should have seen the look on my dogs face. She was so weirded out. Shes highly food motivated so it was like heaven to her but she was simultaneously very suspicious. Her face was like"i love this but idk if i trust it" it was great.Have a greatday!
If you an reinforce the behaviour by arranging frequent, short visits to the vet clinic where nothing happens but lots of treats, she may start to associate the vet clinic with positive things (food) ad no scary things. This might make the rest ofher life easier.
Anonymous said: I own fancy rats and just want to put out there to people, that while they are THE MOST amazing tiny friends, in my experience most vets are completely lost when it comes to their care & several I've seen refused to even touch my exceptionally friendly females. They often get respiratory infections requiring antibiotics. One of my friend's females passed away bc nobody would perform a simple surgery on her. So please be cautious when buying them. 
I would like to suggest that any surgery on a rat is likely to be not simple, because they do have particular anesthetic requirements that can make their recovery difficult. Also that a lot of traditional rat medicine hinges on using post mortem examination as a diagnostic tool, which is not useful at all with pet rats.
In dog and cat medicine most of our equipment and even medications are not suitable for rats, or very difficult to adapt. We simply have fewer options, and generally less experience with these species Most vets I know will attempt to treat them, but with a great big disclaimer saying I don’t do this often, and a quick question as to whether you’d prefer to go to a nearby clinic that does see rats more often.
Anonymous said: Hello, I recently took in 3 abandoned kittens and they're covered in fleas. They appear to be 6 weeks old and can't use meds or wash for them. I clean them with vinegar and dish soap and I was wondering if you knew of any other ways to help them since they hate getting wet. I also use a comb but they dislike that as well.
You can use capstar on kittens from 4 weeks of age, and Revolution from 6, probably earlier. Talk to your vet.
Anonymous asked: Strange question but do you know if that rage syndrome thing can happen in cats also? I know a cat who does that and also acts strangely in general at the same time?
It is not documented in cats, however Feline Hyperesthesia Syndrome may present in a similar way.
Anonymous said: Hey doc! I plan on getting my cat fixed soon and I'm worried about how it'll affect her. She's really skittish and prefers to stay in one room, could getting her fixed make it worse?? I guess like what are the possible behavioral effects is what I'm askin? For the qt: ive been here a while i just dont like or reblog stuff but i came for the vet knowledge and stayed for it too, especially the mythical creatures and dog breed info
She is probably not going to have any long term personality changes from being desexed, though might be out of sorts for a few days after the anaesthetic. If anything they tend to be less stressed because they’re not attracting Toms.
Another Anonymous said: My kitten was neutered yesterday and he's doing great, healing well, playing nonstop, remarkably agile despite the e-collar (navigating small spaces, jumping to high places), eating & drinking well. The vet didn't give us any aftercare instructions but I googled it -- and wish I'd done so before the surgery because I could've prepared better. A lot of it seemed obvious in hindsight but nothing I'd have thought of on my own. Do you have a flier or anything for your patients' humans? 
We send our patients home with aftercare instructions. We have a default one that we print for routine surgery like desexing, and a customized one for non-routine procedures.
We also read it out to our clients when they pick up their pet, and point out that all these instructions are written down, because it’s easy to forget details when you’re worried.
Anonymous asked: I have a question! I saw your desexing cats post and thought I might send it to you. I neutered my male cat but he still sprays and tries to roam the neighborhood. I try to keep him inside best I can. Is there a reason this happens?
It may be stress, but you should consult your vet to rule out any underlying urinary tract issue before assuming so. Your vet should be able to discus the various stress reducing techniques, changes and treatments that are available.
Anonymous asked: Whenever my roommate wakes up before me, she makes bacon for breakfast while the coffee is brewing. If she hasn't slept well, her coherence is sometimes a bit... lacking. If our cat happens to demand food, about half the time she ends up giving him a slice of bacon instead of cat food. We only recently figured out that she's been doing this. He's not getting fat, and gets actual cat food later, so is this OK, or do we need to try to figure out how to keep this from happening?
While bacon is certainly digestible, it is not a balanced diet. It would be ideal if you could minimize his bacon habit.
@nowgovanish said: Hello! I have a question about my 13 and 4 year old cats. They seem to have some pretty bad skin reactions to certain foods, and I've tried a lot of different food brands that my vet reccommended. The one that seems to work best is a grain free/ non chicken variant, but I see that you aren't a huge fan of grain free. Is there anything I should change or try sticking with what works?
I have said many times before that if it’s working, keep feeding it.
Novel protein diets, and ideally single proteins source diets, are more use for allergies than just going ‘grain free’.
‘Grain Free’ labelling on food particularly vexes me because it’s not regulated. You can find ‘grain free’ food that really mean ‘corn free’ and either use grain byproducts or straight up use rice. Last time I checked, rice was a grain.
It’s like ‘Hollistic’ - it means nothing on a pet food label. Neither does ‘Organic’, pet food companies do not have to use all organic products in pet food to label the food as organic. These are marketing ploys like ‘all natural’ which are targeting your emotions and don’t mean anything when it comes to the food.
If you’ve come across a novel protein diet, or a minimum ingredient diet, that is beneficial for your cats then stick with it. But recognise what’s marketing and what’s useful.
Anonymous said: I love my dog but he is a complete and total moron. He has strangled himself so often that his bark is now raspy. He even found a way to do it with a harness! We've resorted to jogging when walking him to try and keep up but is there some way to make it better? We've tried letting him learn on his own, pausing when he pulls, and getting a longer leash. If he was much smarter I'd accuse him of being into asphyxiation.
I would suggest that you potentially need to figure out what motivates your dog most. Consider using positive reinforcement to encourage him to heel on the lead, instead of wandering and pulling.
You might also want to consider something like a halti collar, which pulls the dog’s nose downwards to their chest when they pull, instead of something that goes around the neck.
Anonymous: Would you consider it a good generalization that dogs more closely resembling/related to wolves (like huskies) have less health problems? I am aware that no dogs are completely lacking in health problems.  Tax: came for good hard factual analysis.
No. And here’s the thing- all modern dog breeds are equally distant from their wolf-like ancestor, unless they have been recently mixed with wolves again.
Their health problems are different to those dogs with more extreme anatomy, but dogs that look like wolves are not inherently healthier.
@justslowdown said: a book i have discusses the man who created the GSD breed (aka isolated traits from a diverse population) pairing dogs with their daughters, granddaughters, great-granddaughters and onwards til more than 1/2 of the pups had to be culled. due you think this could be partially responsible for the health issues remaining more than a century later? "Very drastic inbreeding was espoused during the formation of the breed [...] to quickly form specific type" - The German Shepherd Dog by Ernest H Hart
Certainly.
This is called line breeding, where the offspring of a ‘perfect’ individual are repeatedly bred back to the same individual generation upon generation to try to recreate it. All you really do is lose genetic diversity very quickly and allow recessive deleterious genes to proliferate in the population.
This is why just about everywhere else that’s not the purebred pet world, this is considered a bad thing to do.
@eyestumblin said: Do you think horses would look significantly different if their wonky anatomy were more logical?
They would no longer be a horse.
@cirque-du-spoon said: I saw you mention sheep on the horse thread and I spent a fair bit of time on a sheep farm in Wales. The head shepherd once told me "sheep are born, they spend the rest of their life trying to die". Then he opened his landrover door, and the passenger footwell was maybe 6 lambs snuggled up to one of his old motherly collies.
The common phrase down here was “The aim in life of a Merino ewe is to die and take fifty of her friends with her.” It’s not really much of an exaggeration.
Anonymous said: I'm intrigued to hear the faults of sheep, lay it on me!
Oh I will. It’s on my list for a big write up.
@queenalia said: Hi! I love the post about why horses make no sense, and I was wondering if you would do a similar one for sheep (one of the most suicidal animals on earth in my opinion)?
It will definitely be done sometime in the next few weeks. As you understand, it’s not  quick answer.
@vulturegeorge said: Hey Dr.F, after reeding your "horses-are-spindily-legged-disasters" post and your comment about how sheep are worse, I was wondering if you wished to elaborate? I am currently working on a heard of 50 random sheep my uni bought with a ton of lung issues ... so it'd be super interesting to me. Question tax: came for the Lucifer story, stayed for all of your amazing advice & opinions. I hope you are finding balance between vetting and living. cheers!
I promise I will elaborate. I can’t leave a cliff hanger like that and not explain... eventually.
37 notes · View notes
kisan512posts · 4 years ago
Text
HERG Screening -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021
HERG Screening Industry
Description
Wiseguyreports.Com Adds “HERG Screening -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database
hERG Screening Market research report presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 190 companies that are engaged in hERG Screening services and/or production of hERG screening tools/instruments. A global perspective is presented along with regional analysis covering North America, Europe, Asia-Pacific and Rest of World. Compilation of Worldwide Patents and Research related to hERG Screening is also provided. The hERG Screening market size is analyzed in US Dollars and includes 30 exclusive graphically illustrated exhibits.
OUR NEW SAMPLE HAVE BEEN UPDATED NOW WHICH CORRESPOND IN NEW REPORT SHOWING IMPACT OF COVID-19 ON INDUSTRY
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30790-herg-screening-market-research-report
Report Highlights
Human Ether-a-go-go Related Gene (hERG gene) (KCNH2) is an encoder of the potassium ion channel that repolarizes IKr current in the heart. It consists of 6 transmembrane domains which are serially numbered from S1-S6. The abnormalities resulting in this channel can either lead to Long QT syndrome (LQT2) or Short QTsyndrome causing loss of function mutations and gain of function mutations respectively. Both of these are considered as potentially fatal cardiac arrhythmia caused due to repolarisation disturbances of the cardiac action potential. Global hERG screening market is projected to grow at 21.82%, compounded annually from 2005 through 2020. hERG Screening has its major role in the pharmaceutical field in drug release process. Some drugs may prolong the QT interval in normal and healthy individuals and result in QT Syndrome. This side effect has promoted majority of pharmaceutical companies to screen compounds for hERG channel activity in early stages of drug discovery and development process. Many companies are developing cell lines such as HEK 293, and CHO to aid in vitro screening for hERG channel activity.
Report by Chapter
I. Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
II. Report Synopsis: Synopsis of the report summarizes the global hERG screening market. The chapter provides market values in US$ for hERG Screening in several geographic regions including the North America, Europe, Asia-Pacific and Rest of World.
III. Market Dynamics: Market Dynamics chapter provides information on global markets for hERG Screening. The chapter includes global market analysis (in US$) by geographic region; analysis of each region; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. The section includes key market trends and an industry outlook.
IV. Product/Technology Research: This chapter gives an insight into hERG screening market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Importance of hERG screening in the drug discovery process, technology analysis and technology trends is discussed. Various research activities in the field of hERG Screening finds a mention in this chapter.
V. Corporate Directory: This chapter provides a global region-wise list of 190 plus companies, CROs and academic institutions that are engaged in hERG Screening products and/or services.
VI. Patents Information: This chapter provides a compilation of worldwide patents related to hERG screening products/services/technologies.
Leave a Query @ https://www.wiseguyreports.com/enquiry/30790-herg-screening-market-research-report
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=30790
Continued…                                                                                                    
Contact Us: [email protected] Ph: +1-646-845-9349 (US)  Ph: +44 208 133 9349 (UK)
NOTE : Our final report have added the analysis of the impact of COVID-19 on this industry, Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
0 notes
market-research-future · 4 years ago
Text
Long QT Syndrome Market Sales, Supply and Demand By 2027
Segmentation
The global long QT syndrome market is segmented on the basis of type, diagnosis, treatment, and end users. On the basis of the type, the market is segmented into long QT syndrome type 1, long QT syndrome type 2, long QT syndrome type 3, and others. On the basis of the diagnosis, the market is categorized into tests, electrocardiogram (ECG), genetic testing, and others.
On the basis of the treatment, the market is segmented into medication, surgical procedures, and others. On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic labs, research organizations, and others.
Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/5303
The global long QT syndrome market is expected to grow at a CAGR of 8.50% during the forecast period.
The Long QT syndrome market is driven by factors like the prevalence of cardiovascular diseases & diabetes, and growing geriatric population. Moreover, rising per capita healthcare expenditure and increasing R&D expenses by the key players is fuelling the market growth over the forecast period. However, lack of awareness and stringent FDA approvals followed by the high cost of the surgical therapeutics pertaining to this disorder are restraining the market growth.
Regional Analysis
The Americas dominate the global long QT syndrome market. A well-developed healthcare sector, high per capita healthcare expenditures, increasing number of patients suffering from cardiovascular diseases and diabetes are the major drivers for long QT syndrome market in the Americas. Moreover, the presence of developed economies like the U.S. and Canada boosts the market growth within this region.
Europe holds the second largest market share. Availability of funds for research, huge patient population, and government support for research & development will drive the market. Regionally, Europe is divided into Western Europe and Eastern Europe. The Western Europe leads the market within the Europe. However, Eastern Europe is estimated to be the fastest growing region.
Asia Pacific is the fastest growing market. Increasing prevalence of diabetes and growing geriatric population are the major driving factors for the market growth within the region. Moreover, the presence of developing healthcare sector and developing economies within the region are boosting the market growth.
Browse Detailed TOC with COVID-19 Impact Analysis at:https://www.marketresearchfuture.com/reports/long-qt-syndrome-market-5303
The Middle East & Africa holds the least share of the market. Presence of poor economies and stringent government policies especially in the Africa region are the restraining factors for market growth within the region. The Middle East holds a major share of the market within the region. This can be attributed due to huge healthcare expenditures by the developed economies of the region.
Key Players
The key players for the global long QT syndrome market are Invitae Corporation (U.S.), GeneDx. (U.S.), Asper Biogene (Estonia), Boston Scientific Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), Pfizer Inc. (U.S.), Zydus Pharmaceuticals, Inc. (U.S.), Aralez Pharmaceuticals Inc. (Canada), AstraZeneca (U.K), Torrent Pharmaceuticals Limited (India), Lupin Pharmaceuticals, Inc. (U.S.), Cipla Inc. (India), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), and others.
Browse More Related Reports at:
Cancer Registry Software Market Type, Application | Global Industry Report – 2024
Medical Marijuana Market Statistics | Global Industry Size, Growth, And Forecast To 2027
CAR T Cell Therapy Market Size, Share, & Trends Analysis | Forecast to 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
0 notes
daniablub · 5 years ago
Text
Comorbidities Can Make Long-QT Syndrome a Package Deal
Some diabetes and various neurologic and psychiatric disorders may share a genetic etiology with long-QT syndrome, suggests a population-based study. Medscape Medical News from Medscape Medical News Headlines https://ift.tt/2rFn9PV via IFTTT
0 notes
kraftresearch2019 · 5 years ago
Text
Long QT Syndrome Treatment Market Size, Industry Survey, Competitive Trends, Outlook and Forecasts 2019 to 2024
The report supplies a holistic summary of this global Long QT Syndrome Treatment market 2019 -2024 with the assistance of application segments and leading geographic regions that regulate the industry currently.
The Long QT Syndrome Treatment report 2018 supplies a comprehensive and skilled study on the state of the worldwide industry together with sales forecast and landscape, and share 2024. The Long QT Syndrome Treatment analysis introduced the fundamentals: product specifications, applications, and industry review; industry policies and plans; definitions; fabricating procedures; cost arrangements, and so forth.
Subsequently it studies the crucial global region requirements, for example, price, profit, capacity, production, capacity use, distribution, demand and industry development speed, etc. The Long QT Syndrome Treatment report introduced analysis, investment feasibility, and SWOT analysis. Meanwhile, the chief search is performed connected to the conveyance region, station, and product types, with the key application.
Access Exclusive Free Sample Report at: https://www.researchkraft.com/request-sample/953206
Competitive Analysis:
Our research analysts also have taken significant account facets and landscape scenario like Long QT Syndrome Treatment industry market placement plan frame, and competitive atmosphere for providing a competitive analysis. For company profiling, product analysis, initiatives, and operation of players.
These Players are covered in this Report:
Boston Scientific, Cadila Healthcare, Pfizer, AstraZeneca, Lupin Pharmaceuticals, Cipla, Mylan, Teva Pharmaceutical, Old API Wind-Down, Torrent Pharmaceuticals
Long QT Syndrome Treatment Market Based on Types:
Medication
Surgery Therapy
Long QT Syndrome Treatment Market Based on Applications:
Hospitals
Clinics
Others
Get it in Discounted Price: https://www.researchkraft.com/check-discount/953206
Market Segment by Regional analysis ensures:
Americas, United States, Canada, Mexico, Brazil, APAC, China, Japan, Korea, Southeast Asia, India, Australia, Europe, Germany, France, UK, Italy, Russia, Spain, Middle East & Africa, Egypt, South Africa, Israel, Turkey, GCC Countries
Our report provides:
Global Long QT Syndrome Treatment Market share evaluations for regional and country level sections; Market share analysis of the industry players;
Present tips to the newest entrants;
Market predictions by 2025 of the mentioned the niches, sub-sections along with sections;
Economy Trends (Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Tips);
Tactical tips in key Long QT Syndrome Treatment industry segments centered in the market estimations;
Aggressive landscaping mapping is the main element global Long QT Syndrome Treatment market trends that are prevalent;
Company profiling with financials, plans, and recent advancements; Supply series trends mapping technological advances;
Any Query? Ask Our Expert at: https://www.researchkraft.com/send-an-enquiry/953206
Customization of this Report: This Long QT Syndrome Treatment report could be customized to the customer's requirements. Please contact our sales professional ([email protected]), we will ensure you obtain the report which works for your needs.
0 notes